Contact this trialFirst, we need to learn more about you.
Nicotinic Acetylcholine Receptor Agonist
Nicotine Patch for Mild Cognitive Impairment
Recruiting0 awardsPhase 2
Atlantis, Florida
This trial will test if daily transdermal nicotine can improve cognitive, clinical, and functional outcomes in people with mild cognitive impairment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.